CONTROL OF PHENOTYPIC-EXPRESSION OF CULTURED B-16 MELANOMA-CELLS BY PLANT GLYCOSIDES
- 1 January 1985
- journal article
- research article
- Vol. 45 (6) , 2781-2784
Abstract
The effects of 2 plant glycosides, ginsenosides Rh1 and Rh2, on the growth and differentiation of mouse melanoma (B16) cells in culture were studied. These plant glycosides have a dammarane skeleton resembling a steroid skeleton as an aglycone. Ginsenoside Rh2 inhibits the growth of B16 melanoma cells, causes morphological alterations and stimulates melanogenesis at high cellular density. When ginsenoside Rh2 was removed after 2 or 6 days of treatment, the growth rate recovered slightly but not completely, during the period of observation (4 days after removal). Ginsenoside Rh1 does not inhibit the growth of melanoma cells even at concentrations > 100 .mu.M but stimulates the expression of the melanotic phenotype. Ginsenosides Rh1 and Rh2, possessing a glucose molecule at C-6 and C-3, respectively, have very similar chemical structures, but their effects on B16 melanoma cells differ remarkably. While it appears that the degree of differentiation is inversely related to cell growth, the present observations suggest that the differentiation and growth capacity of this B16 melanoma subline are independent phenotypic expressions.This publication has 3 references indexed in Scilit:
- Glucocorticoid hormone modulation of both cell surface and cytoskeleton related to growth control of rat glioma cells.The Journal of cell biology, 1983
- Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycleJournal of Cellular Physiology, 1983
- The suppression of cellular proliferation in SV40-transformed 3T3 cells by glucocorticoidsJournal of Cellular Physiology, 1980